ArticleJournal of the American Geriatrics Society2018
Insomnia in Community-Living Persons with Advanced Age.
Article in Journal of the American Geriatrics Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.
- The Prevalence of Insomnia Disorder in the General Population: A Meta-Analysis.Journal of sleep research · 2025Pooled it
- Article
- Lower slow wave sleep and rapid eye movement sleep are associated with brain atrophy of Alzheimer's disease-vulnerable regions.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025Article
- Lower slow wave sleep and rapid eye-movement sleep are associated with brain atrophy of AD-vulnerable regions.bioRxiv : the preprint server for biology · 2025Article
- MindMInC (mindfulness intervention for insomnia, mood, and cognition): a digital randomized control trial protocol for improving sleep and wellbeing in older adults.Sleep advances : a journal of the Sleep Research Society · 2025Article
- Effects of combined morbid insomnia and sleep apnea on long-term cardiovascular risk and all-cause mortality in elderly patients: a prospective cohort study.BMC geriatrics · 2024Article
- The association between wealth and sleep medication use in a nationally-representative sample of older Medicare beneficiaries.Pharmacoepidemiology and drug safety · 2024Article
- Insomnia Severity and Daytime Sleepiness in Caregivers of Advanced Age.Frontiers in sleep · 2024Article
- Article
- Insomnia with objective short sleep duration in community-living older persons: A multifactorial geriatric health condition.Journal of the American Geriatrics Society · 2023Article
- Socioeconomic status and sleep health: a narrative synthesis of 3 decades of empirical research.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2023Review
- Sleep Deficiency in the Elderly.Clinics in chest medicine · 2022Review
- Socioeconomic Position and Excessive Daytime Sleepiness: A Systematic Review of Social Epidemiological Studies.Clocks & sleep · 2022Review
- Self-reported and actigraphic short sleep duration in older adults.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2022Article
- Nursing Home Eligible, Community-Dwelling Older Adults' Perceptions and Beliefs About Sleep: A Mixed-Methods Study.Clinical nursing research · 2020Article
- Insomnia and its associated factors among older people of selected ward of Banepa municipality, Nepal.Nursing open · 2020Article
- Anticholinergic and sedative medications exposure in older patients: a cross-sectional study.International journal of clinical pharmacy · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 1 country.
Funding
Abstract
objectiveTo evaluate the epidemiology of insomnia, including demographic and clinical correlates, in older adults.
designCross-sectional.
settingCommunity.
participantsYale Precipitating Events Project participants (N=379; mean age 84.3; 67.8% female; 11.9% African American). MEASUREMENTS: Insomnia Severity Index (ISI), with scores of 8 and higher indicating insomnia, which was further stratified according to ISI score as mild (8-14), moderate (15-21), or severe (22-28). Baseline characteristics included age, sex, race, education, smoking, obesity, medical conditions, depressive symptoms (Center for Epidemiologic Studies Depression score ≥16), cognitive impairment (Mini-Mental State Examination score <24), restless legs syndrome (RLS), self-reported sleep-disordered breathing (SDB), medications, and daytime sleepiness (Epworth Sleepiness Scale (ESS), range 0-24).
resultsInsomnia was established in 163 (43.0%) participants (average ISI score 12.3 (mild)). For the entire sample, average baseline characteristics were as follows: 30.1% did not complete high school, 5% were current smokers, 19.2% were obese, 28.2% had cardiovascular disease, 19.3% had chronic lung disease, 27.2% had depressive symptoms, 16.1% had cognitive impairment, 36.8% had RLS, and 3.4% had self-reported SDB; mean number of medications was 9.2, and mean ESS was 6.4. In multivariable regression models, only depressive symptoms (adjusted odds ratio (aOR)=8.34, 95% confidence interval (CI)=4.49, 15.47) and RLS (aOR=2.49, 95% CI=1.48, 4.21) were significantly associated with insomnia.
conclusionIn a sample of older adults with high medical burden and polypharmacy, insomnia was highly prevalent but unexpectedly mild and associated only with depressive symptoms and RLS. The discordance of high prevalence but mild severity of insomnia in the oldest adults highlights the need for diagnostic confirmation with objective measures of sleep disturbances, whereas the strong associations with depressive symptoms and RLS inform priorities in managing insomnia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.